Match Document Document Title
US20110150983 CONCENTRATED, INHALABLE CIPROFLOXACIN FORMULATION  
A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposomes which incorporate antibiotic. The...
US20110182831 SYSTEMS AND METHODS USED IN CONJUNCTION WITH NICOTINE VACCINES FOR EFFECTING CESSATION OF TOBACCO USE  
The invention relates generally to a system and method for treating conditions responsive to nicotine therapy. More specifically, the invention relates to administering a nicotine vaccine or...
US20110008269 Compositions and Methods Which Modulate G-Protein Signaling for the Treatment of Inflammatory Disorders such as Asthma and Allergic Conjunctivitis  
Compositions and methods for the treatment of asthma and inflammatory ocular disorders are disclosed.
US20120308617 PHOSPHOLIPID-BASED INHALATION SYSTEM  
The present invention includes a method for delivering medications deeper into the lungs and to the medications' pulmonary targets, which include bronchioles and alveoli. A first particularly...
US20130167838 NASAL FORMULATION  
This invention relates to a solution formulation for nasal administration comprising azelastine, beclomethasone dipropionate, a co-solvent, an acid and an HFA propellant.
US20110123624 FORMULATIONS COMPRISING AMINOSTEROLS  
This invention relates to stable aminosterol phosphate compositions. The aminosterol phosphate compositions permit administration without associated tissue damage and achieve a sustained release...
US20120082627 OTIC FOAM FORMULATIONS  
The present invention relates to foamable otic pharmaceutical compositions comprising fluoroquinolones and methods of preparing same. Particularly, the present invention relates to pharmaceutical...
US20120149570 Foamable Pesticide Compositions And Methods Of Application  
Ready-to-use foamable pesticide compositions that contain a pesticide dispersed in a composition containing water, a co-solvent, surfactant and propellant. Methods for treating pests such as...
US20110045037 FOAM CONTAINING BENZOYL PEROXIDE  
The present invention relates to foamable compositions for treating acne comprising benzoyl peroxide; to a therapeutic kit comprising such compositions; and to a method of treating acne using such...
US20110189104 SURFACTANT PROTEIN D FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LUNG INJURY  
Surfactant protein D (SP-D) is a 43-kDa member of the collectin family of collagenous lectin domain-containing proteins that is expressed in epithelial cells of the lung. Described herein are...
US20110038807 COMPOSITIONS AND METHODS FOR TREATING BIPOLAR DISORDER  
The present invention is directed to a method for treating bipolar disorder, childhood-onset bipolar disorder, and associated symptoms. The method includes administering to a subject in need of...
US20110076324 Use of Histamine H4 antagonist for the treatment of post-operative adhesions  
The present invention includes methods for the inhibition of post-operative adhesion formation between tissue surfaces in a body cavity having been subjected to a surgical procedure, which methods...
US20110301617 System and Method for Immobilizing a Tick on a Host  
Provided is a system and method for immobilizing and killing a tick on a host, allowing for removal of the tick without triggering of the tick's regurgitation reflex. Further provided are...
US20130095044 USE OF STREPTOCOCCUS SALIVARIUS IN THE TREATMENT OF CHRONIC INFECTIONS OF THE RESPIRATORY TRACT  
A new microbial strain of the species Streptococcus salivarius for use in the treatment of inflammatory processes with or without infectious etiology. A further object of the present invention...
US20090011022 Use of deuterium oxide for treatment of virus-based diseases of the skin  
The present invention relates to the use of deuterium dioxide (D2O) for prevention and/or treatment of virus-based diseases of the skin, in particular herpes virus-based and verrucal virus-based...
US20120058058 COMPOUNDS DERIVED FROM MUSCODOR FUNGI  
The present invention relates to novel compounds and compositions and the use of them for the control of fungal and bacterial pathogens, insect pests, acari, nematodes and other invertebrate pests...
US20140105942 AQUEOUS WAX DISPERSIONS  
The present invention is directed to an aqueous dispersion comprising: (a) at least one solid wax particle having a particle size ranging from equal to or greater than 1 micron to about 100...
US20130098357 CERIVASTATIN TO TREAT PULMONARY DISORDERS  
Pharmaceutical formulations and methods of using thereof for the treatment and prevention of pulmonary arterial hypertension are provided. The formulations contain one or more agents to...
US20110229418 Compositions and Methods of Treating and Preventing Lung Cancer  
Compositions and methods for treating and preventing cancer, particularly lung cancer, are provided.
US20130004436 Compositions and Methods of Treating and Preventing Lung Cancer and Lymphangioleiomyomatosis  
Compositions and methods for treating and preventing cancer, particularly lung cancer, lymphangioleiomyomatosis and asthma are provided.
US20110311462 COMPOSITIONS FOR TREATMENT OF EAR DISORDERS AND METHODS OF USE THEREOF  
The present invention relates to compositions and methods useful for the treatment of ear disorders, administered to a treated ear in the form of a foam or a mousse. Administering a medicament in...
US20120265129 Methods for Chronic Pain Management and Treatment using HCG  
A gonadotropin is administered within a surprisingly effective narrow range for the purpose of treating chronic pain or other central sensitization sequelae. In one aspect, a recipient is provided...
US20110171142 Metformin glycinate salt for blood glucose control  
The present invention relates to metformin glycinate salt and pharmaceutical compositions thereof for the treatment of diabetes mellitus. The method includes administration of the metformin...
US20140079784 AEROSOLIZED LFA-1 ANTAGONISTS FOR USE IN LOCALIZED TREATMENT OF IMMUNE RELATED DISORDERS  
This invention provides specifically formulated LFA-1 antagonists or pharmaceutically acceptable salts thereof that are suitable for aerosolized delivery. In particular, the LFA-1 antagonists are...
US20120125325 THE USE OF AMLEXANOX IN THE THERAPY OF NEUTROPHIL-DRIVEN DISEASES  
An agent, which is amlexanox, is useful in the therapy of a disease associated with neutrophilia.
US20120093883 METHOD OF TREATING AND PREVENTING NEURO-OLFACTORY TRIGGERED OR AGGRAVATED ILLNESSES OR RELATED CONDITIONS  
A method for treating at least one of neuro-olfactory triggered illnesses, and related conditions within a subject is provided. The method includes the steps of: a) providing a composition that...
US20140294737 TREATMENT OF RHINITIS  
The invention provides a method of treating rhinitis. The method comprises administering an effective amount of a danazol compound or a pharmaceutically acceptable salt thereof. The invention also...
US20110165095 COMPOSITION AND METHOD FOR THE INHIBITION OF POSTOPERATIVE ADHESIONS SEVERITY  
The present invention refers to the use of growth factors, which are effective on mesothelial cell proliferation, used in a sterilized carboxymethylchitosan pharmaceutical composition employed to...
US20150023888 Method of Using Dihydroergotamine for Pre-emptive Treatment of Migraine  
The invention is drawn to a novel, early interventional use of a pharmaceutical composition wherein administration of said pharmaceutical composition pre-empts the onset of migraine headaches,...
US20140186269 VEHICLE COMPOSITIONS ESSENTIALLY FREE OF PHARMACEUTICALLY ACTIVE AGENTS FOR THE IMPROVED TREATMENT OF ACNE AND RELATED DISORDERS  
The present invention related to the use of a pharmaceutical composition which is essentially free of pharmaceutically active agents for the treatment of human skin, especially in the treatment of...
US20110293535 COMPOSITION FOR BUCCAL ABSORPTION OF NICOTINE FOR THE PURPOSE OF SMOKING CESSATION  
Composition intended for buccal absorption of nicotine into the system circulation and distribution to the central nervous system for the purpose of smoking cessation or nicotine substitution in...
US20140308215 ANTIPERSPIRANT COMPOSITIONS AND METHOD FOR REDUCING PERSPIRATION  
An anhydrous antiperspirant composition comprising a dehydrated alum salt, a water soluble calcium salt, and a liquid carrier material comprising 50% or more by weight of hydrophobic oils.
US20100158819 Calcium Glycerophosphate for Treating and Preventing Respiratory Diseases or Conditions  
Calcium glycerophosphate is found to be effective in treating and preventing a disease, disorder and/or condition of the respiratory system. The disease, disorder and/or condition is related to an...
US20110305645 CRYSTAL FORM OF GLYCOPYRRONIUM CHLORIDE  
A new crystal form of threo glycopyrronium chloride is useful in pharmaceutical applications.
US20140079648 ANTIMICROBIAL ALCOHOLIC FOAMABLE COMPOSITIONS  
An antimicrobial alcoholic foamable composition comprising an alcohol, a waxy component, water, and a dissolvable gas, where the composition is dispensed and foamed without requiring the use of a...
US20120058056 TREATMENT OF CUTANEOUS HEMANGIOMA  
This invention concerns a method of treating hemangiomas with a beta blocker by applying the beta blocker onto the hemangiomas directly. The invention also concerns a combination therapy by using...
US20080311206 Anti-Chafing Compositions Comprising Boron Nitride  
The invention in one aspect relates to an anti-chafing composition with improved efficacy, in one embodiment, comprising an effective amount of boron nitride suspended in a dermatologically...
US20090280069 PROGUANIL TO TREAT SKIN/MUCOSAL DISEASES  
Proguanil has been found to have rapid and effective killing activity against a variety of disease-causing micro-organisms. For example, when applied topically, proguanil is particularly effective...
US20150231072 Stabilized, Sprayable Emulsion Containing Active Agent Particles  
A sprayable emulsion is provided. The emulsion can be used in the treatment of various skin conditions. The emulsion includes a hydrofluoro-based propellant, an emulsification system, an oil...
US20140377365 SUSTAINED-RELEASE FORMULATION OF ROTIGOTINE  
Provided herein are methods and compositions for producing formulations systemic delivery of dopamine agonists via the oral inhalation route. Specifically, provided herein are methods and...
US20120070384 TOPICAL ANTIFUNGAL COMPOSITION  
A topical, foamable composition is provided that includes at least one antifungal agent that is able to penetrate the upper layers of skin and is retained in or on an area to be treated for a...
US20090196833 COMPOSITIONS COMPRISING TOPICAL DPD INHIBITORS AND METHODS OF USING SAME IN THE TREATMENT OF HAND-FOOT SYNDROME  
Topical formulations comprising inhibitors of dihydropyrimidine dehydrogenase (DPD), thymidine phosphorylase (TP) and/or uridine phosphorylase (UP) enzyme inhibitors are provided for the treatment...
US20060193784 Scopolamine sublingual spray for the treatment of motion sickness  
This invention relates to a scopolamine spray for sublingual administration, used in the treatment and prevention of motion sickness, as well as the treatment and prevention of similar symptoms,...
US20060062739 Inhalable lidocaine formulation for treatment of asthma and for reducing the need for corticosteroids in asthmatic patients  
An inhalable lidocaine solution for treatment of asthma and a method for treatment of asthma with the reduced need for concurrent administration of oral corticosteroids in asthmatic patients. The...
US20150017247 COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING B2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS  
Compositions, methods and systems are provided for pulmonary delivery of long-acting muscarinic antagonists and long-acting β2 adrenergic receptor agonists via a metered dose inhaler. In...
US20110132356 COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING B2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS  
Compositions, methods and systems are provided for pulmonary delivery of long-acting muscarinic antagonists and long-acting β2 adrenergic receptor agonists via a metered dose inhaler. In...
US20070020191 Potentiation of glucose elimination  
Methods related to the treatment of diabetes and improving the efficiency of insulin utilization are provided. The method enables effective control of prandial glucose levels while reducing the...
US20070237723 TREATMENT OF COUGH WITH INTERFERON  
A method of treating chronic coughing in a patient comprising administering to the patient an effective amount of interferon; a method of treating idiopathic pulmonary fibrosis in a patient...
US20150202126 FOAMING SKINCARE FORMULATIONS  
In one aspect, the present invention is directed to formulations comprising at least one pressure generating vehicle along with at least one skincare active agent in a container such that the...
US20120189556 PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND CORTICOSTEROIDS  
A pharmaceutical composition comprising an anticholinergic and a steroid, optionally together with a pharmaceutically acceptable excipient, the anticholinergic and the steroid optionally in the...